Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

GENMAB A/S (GMAB)

  • Business News
  • June 02, 2026, 12:59 UTC
  • 1
  • 1 comments

Clinical trial NCT04623541: enrollment: 195 → 194 participants.

Market reaction Comment Full text

BRISTOL MYERS SQUIBB CO (BMY)

  • Business News
  • June 02, 2026, 12:59 UTC
  • 1
  • 1 comments

Clinical trial NCT03771859 updates: 1. status: UNKNOWN → COMPLETED 2. completion date: 2025-12-30 → 2025-12-09 3. primary completion date: 2025-12-30 → 2025-12-09

Market reaction Comment Full text

GUARDANT HEALTH, INC. (GH)

  • Business News
  • June 02, 2026, 12:59 UTC
  • 1
  • 1 comments

Clinical trial NCT07436637: start date: 2026-05-30 → 2026-06-30.

Market reaction Comment Full text

ASTRAZENECA PLC (AZN)

  • Business News
  • June 02, 2026, 12:59 UTC
  • 1
  • 1 comments

Clinical trial NCT05952024 updates: 1. completion date: 2027-08-24 → 2029-04-22 2. primary completion date: 2027-08-24 → 2029-04-22

Market reaction Comment Full text

BAYER A.G. (BAYZF)

  • Business News
  • June 02, 2026, 12:59 UTC
  • 1
  • 1 comments

Clinical trial NCT05348733 updates: 1. completion date: 2026-12-15 → 2027-12-15 2. primary completion date: 2026-09-30 → 2027-09-01

Market reaction Comment Full text

MERCK & CO., INC. (MRK)

  • Business News
  • June 02, 2026, 12:59 UTC
  • 0
  • 1 comments

Clinical trial NCT07595263: start date: 2026-06-15 → 2026-06-30.

Market reaction Comment Full text

GLADSTONE LAND CORP (LAND)

  • Business News
  • June 02, 2026, 12:59 UTC
  • 0
  • 1 comments

Landsvirkjun’s first quarter results

Market reaction Comment Full text

GLADSTONE LAND CORP (LAND)

  • Business News
  • June 02, 2026, 12:59 UTC
  • 0
  • 1 comments

Þriggja mánaða uppgjör Landsvirkjunar

Market reaction Comment Full text

MEDTRONIC PLC (MDT)

  • Business News
  • June 02, 2026, 12:58 UTC
  • 0
  • 1 comments

Clinical trial NCT03320252: primary completion date: 2026-03-01 → 2026-04-22.

Market reaction Comment Full text

TAKEDA PHARMACEUTICAL CO LTD (TAK)

  • Business News
  • June 02, 2026, 12:58 UTC
  • 0
  • 1 comments

Clinical trial NCT06550076 updates: 1. completion date: 2026-05-07 → 2029-08-05 2. primary completion date: 2026-05-07 → 2029-08-05 3. enrollment: 1950 → 2099 participants 4. enrollment type: ESTIMATED → ACTUAL

Market reaction Comment Full text

BRISTOL MYERS SQUIBB CO (BMY)

  • Business News
  • June 02, 2026, 12:58 UTC
  • 0
  • 1 comments

Clinical trial NCT05161325 updates: 1. completion date: 2026-06-01 → 2027-03-31 2. primary completion date: 2025-12-31 → 2026-12-31

Market reaction Comment Full text

BRIDGEBIO PHARMA, INC. (BBIO)

  • Business News
  • June 02, 2026, 12:58 UTC
  • 0
  • 1 comments

Clinical trial NCT06917079: enrollment: 387 → 665 participants.

Market reaction Comment Full text

NOVARTIS AG (NVSEF)

  • Business News
  • June 02, 2026, 12:58 UTC
  • 0
  • 1 comments

Clinical trial NCT03876769: primary completion date: 2025-08-20 → 2027-10-19.

Market reaction Comment Full text

MEDTRONIC PLC (MDT)

  • Business News
  • June 02, 2026, 12:58 UTC
  • 0
  • 1 comments

Clinical trial NCT07120945: status: RECRUITING → ACTIVE_NOT_RECRUITING.

Market reaction Comment Full text

TARSUS PHARMACEUTICALS, INC. (TARS)

  • Business News
  • June 02, 2026, 12:58 UTC
  • 0
  • 1 comments

Clinical trial NCT07457086: status: NOT_YET_RECRUITING → RECRUITING.

Market reaction Comment Full text
  • Previous
  • 1127
  • 1128
  • 1129
  • 1130
  • 1131
  • Next

Search

News categories

  • Technical Exchange News(13024)
  • Event(6229)
  • SEC News(322732)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(181763)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin